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A B S T R A C T CD4
+ T reg -cells (regulatory T-cells) probably contribute to the impaired virus-specific T-cell responses in chronic HCV (hepatitis C virus) infection; however, their antigen-specificity has remained elusive. In the present study, we analysed peripheral blood CD4
+ T reg -cells in patients with chronic hepatitis C and subjects with self-limited HCV infection and characterized individual T reg -cell clones obtained from both groups at the phenotypic and functional level. Foxp3 (forkhead box p3) + CD25 + CD4 + T reg -cells were detected more frequently in patients with chronic hepatitis C than self-limited HCV infection, which responded to HCV core stimulation and inhibited proliferation of reporter cells. Cloning under limiting dilution conditions resulted in 14 and six hypoproliferative Foxp3 + CD25 + CD127 − CD4 + T-cell clones from patients with chronic hepatitis C and subjects with self-limited HCV infection respectively. All clones expressed T reg -cell markers and produced IL (interleukin)-10 upon mitogen stimulation. However, exclusively T reg -cell clones from chronic hepatitis C produced IL-10 in response to HCV core and inhibited proliferation of reporter T-cells. These core-specific T reg -cell clones recognized epitopes in two regions of HCV core (amino acids 1-44 and 79-113). Co-culture inhibition assays demonstrated T reg -cells to inhibit reporter T-cells via secretion of IL-10 and IL-35 rather than cell-contact-dependent mechanisms. Finally, the HCV-specific T reg -cell clones lost their functional capacity, along with Foxp3 expression, if kept in culture without HCV core exposure. In conclusion, we identified functionally active HCV core-specific T reg -cells in patients with chronic hepatitis C, which share their epitopes with conventional T-cells and require the continued presence of antigen to maintain their functional differentiation. Thus HCV core-specific T reg -cells may contribute to the immunoregulatory balance in chronic hepatitis C.
INTRODUCTION
HCV (hepatitis C virus) efficiently establishes chronic persistency in the majority of individuals who encounter the infection and, thus, it is one of the leading causes of chronic liver disease in the world [1] . Although strong and multi-specific lymphocyte responses, including CD4 + and CD8
+ T-cells, NK (natural killer) cells and dendritic cells, contribute to viral elimination, chronic hepatitis C is associated with inefficient and delayed T-cell responses [2] . Although the mechanisms of impaired antiviral immunity in patients with chronic hepatitis C are only incompletely understood, it has been proposed that CD4
+ T reg -cells (regulatory T-cells) might contribute to T-cell dysfunctions during ongoing HCV infection.
Several studies have demonstrated an overall increased frequency of CD25 high CD4 + T reg -cells in chronic hepatitis C which produce IL (interleukin)-10 [3] and TGF (transforming growth factor)-β [4] , express Foxp3 (forkhead transcription factor box 3) [5] , can suppress IFN-γ (interferon-γ ) production [6] and proliferation of virus-specific CD8
+ T-cells [7, 8] . Thus far, analysed T reg -cells carry phenotypic and functional characteristics of so-called natural CD4
+ T reg -cells [9, 10] , because they are Foxp3
+ [5] , express high levels of CD25 [3] [4] [5] and predominantly inhibit reporter cells via contact-dependent mechanisms [3, 4, 6, 8] . Since, thus far, expansion of T reg -cells in chronic hepatitis C is largely considered to reflect HCV non-specific T reg -cells, the role of HCV-specific adaptive T reg -cells has still remained a matter of debate.
Antigen-induced adaptive T reg -cells are generated in the periphery upon antigen exposure inhibiting effector T-cells via release of the immunosuppressive cytokines IL-10 and TGF-β [11] [12] [13] . In general, adaptive T regcells exhibit heterogeneous phenotypes with variable expression of CD25 and Foxp3 and can be subdivided further according to their individual phenotypes and cytokine profiles [13, 14] .
The HCV core protein is highly conserved among different HCV isolates [15] and is frequently recognized by the host's cellular antiviral immune response [16] . Thus HCV core is an exquisite model antigen to search for HCV-induced adaptive T reg -cells in chronic hepatitis C. Studying subjects with different outcomes of HCV infection offers an opportunity to understand the relationship of T reg -cells with continued antigen exposure. With this approach, we studied HCV corespecific T reg -cells in the peripheral blood of patients with chronic hepatitis C and compared them with corresponding cells in anti-HCV-positive subjects who had resolved their infection spontaneously.
MATERIALS AND METHODS

Study groups
PBMCs (peripheral blood mononuclear cells) were isolated by Ficoll-Paque gradient centrifugation (PAA Laboratories) from heparinized blood of 31 treatmentnaïve non-cirrhotic patients with chronic hepatitis C [15 males and 16 females; age, 46 (30-68) years; median (range)], and 12 subjects with self-limited HCV infection [all males; age, 43 (27-65) years]. Patients with chronic hepatitis C had detectable HCV RNA genotype 1 by PCR for more than 6 months. Stages of fibrosis were obtained either by histology or Fibroscan and are reported as Metavir scores. Subjects with selflimited HCV infection consisted of carefully selected individuals who had spontaneously recovered from a well-documented episode of acute hepatitis infection 27 months to 30 years prior to the study, which in retrospect had unequivocally been identified as hepatitis C. All control subjects were anti-HCV positive (HCV version 3.0, AXSYM System; Abbott), but had consistently normal aminotransferases and a negative HCV PCR on repeated assessment. The clinical data of both study groups are summarized in Table 1 .
The study has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association and has been approved by the local ethics committee. Informed consent had been obtained prior to inclusion into the study.
Reagents
Recombinant HCV core protein [genotype 1, amino acids 1-115; <4.0 pg/μg of LPS (lipopolysaccharide)] was purchased from Mikrogen. For epitope mapping a 25-mer HCV peptide panel (P1-P12) covering region amino acids 1-133 of the HCV core protein with a ten amino acid overlap was synthesized as described previously [17, 18] .
Human rIL-2 (recombinant IL-2) was obtained from R&D Systems, anti-CD28 from BD Biosciences, OKT-3 (human anti-CD3) from Janssen-Cilag, and CMV (cytomegalovirus) glycoprotein p65 from AUSTRAL Biologicals.
RPMI 1640 medium supplemented with 10 % (v/v) human AB serum, 200 mg/ml glutamine, 50 μg/ ml gentamycin, 100 units/ml penicillin and 100 μg/ml streptomycin (all from PAA Laboratories) was used for cell culture.
Analysis of CD4
+ T reg -cell subsets prior to in vitro expansion
To identify the spectrum of CD4 + T reg -cells prior to in vitro expansion, subsets of CD4 + T-cells carrying T reg -cell markers were quantitatively determined by flow cytometry in freshly isolated PBMCs from patients with chronic hepatitis C and subjects with self-limited HCV infection. Next, PBMCs were studied after a single round of in vitro stimulation with HCV core to search for HCV-responsive cells. In brief, PBMCs (5 × 10 5 cells/well) were stimulated with HCV core protein (10 μg/ml) in culture medium for 10 days. PBMCs were stained with anti-CD25 [PE (phycoerythrin)-labelled], anti-CD4 [allophycocyanin-labelled], and anti-Foxp3, anti-GITR (glucocorticoid-inducible tumour necrosis factor receptor), anti-CTLA-4 (cytotoxic T-lymphocyte antigen-4), anti-PD1 (programmed death 1) and anti-CD134 (all FITC-labelled). 
Generation and characterization of HCV-specific T reg -cell clones
Generation of T reg -cell clones was achieved by adapting previously established protocols [19, 20] . In detail, freshly isolated PBMCs (5 × 10 5 cells/ml) were stimulated with core protein (10 μg/ml) and cultured in medium with rIL-2 (100 units/ml). After 10 days, cells were restimulated with HCV core protein and supplemented with irradiated autologous feeder cells (5 × 10 5 PBMCs/ml). After 20 days, cells were re-stimulated for 72 h with PHA (phytohaemagglutinin; 1 μg/ml) together with irradiated feeder cells. Next, cells were seeded in Terasaki plates (Greiner Bio-one) under conditions of limiting dilution (0.1 and 0.3 cells/well). After 10 days, clones were picked from plates with <10 % positive wells and restimulated at 10-14 day intervals in the presence of rIL-2.
Clones were classified as T reg -cells by analysing proliferation and cytokine secretion (IL-4, IL-10, IFN-γ , TGF-β1) in response to either HCV core protein or anti-CD3/anti-CD28. Recombinant CMV p65 (10 μg/ml) served as a control antigen to check HCV specificity. Functional and phenotypic studies were always performed in the resting phase 10 days after restimulation. In the presence of antigen, T-cell clones maintained their original functionality for culture periods of up to 100 days. Figure S1 at http://www.ClinSci.org/cs/119/cs1190097add.htm) [21] .
Flow cytometric analysis of T reg -cell clones
Proliferative responses of HCV core-specific T reg -cell clones
Cells (5 × 10 4 ) from each prospective HCV-specific T reg -cell clone were stimulated with either HCV core protein (10 μg/ml) or anti-CD3/anti-CD28 (1 and 2.5 μg/ml), together with 1 × 10 5 irradiated autologous APCs (antigen-presenting cells). After 4 days, cultures were pulsed with 1 μCi of [ 3 H]thymidine for 18 h. Incorporated radioactivity was measured by liquid-scintillation spectrometry (TopCount ® NXT; PerkinElmer Life Sciences). SIs (stimulation indices) were calculated as the ratio of [ 3 H]thymidine uptake relative to the medium controls. SIs >5 were considered positive.
Cytokine profiles of HCV core-specific T reg -cell clones
Cells (1 × 10 5 ) of each candidate T reg -cell clone were stimulated separately either with HCV core protein or anti-CD3/anti-CD28. At 72 h after stimulation, supernatants were harvested to measure IL-4, IFN-γ , IL-10 and TGF-β1 by ELISA. TGF-β1 was determined using the OptEIA human TGF-β1-Set from BD Biosciences. IL-4, IL-10 and IFN-γ were captured with primary antibodies 8D4-8, JES3-9D7 and NIB42 and bound cytokines were detected with the corresponding antibodies MP4-25D2, JES3-268 and S.B3 (all BD Biosciences) respectively. Plates were measured in an ELISA reader (Orgentec) at 450 nm. Cytokine values >50 pg/ml were considered positive and defined as high if >250 pg/ml. Clones were classified as Th (Thelper) 1, Th2 and T reg -cells based on cytokine and proliferation profiles in response to anti-CD3/anti-CD28 stimulation (see Supplementary Table S1 at http://www.ClinSci.org/cs/119/cs1190097add.htm).
HLA-restriction of HCV core-specific T reg -cell clones
HLA-restriction was determined by blocking HCV core-specific IL-10 production with antibodies L243 Table 2 CD4 + T reg -cell subsets in unexpanded PBMCs at baseline and after short-term in vitro stimulation with HCV core
Values are means + − S.E.M. The T-cell subset composition was measured in freshly isolated PBMCs 10 days after stimulation with HCV core (10 μg/ml). Of note, results in patients with self-limited HCV infection were similar to a group of healthy controls (results not shown). * P < 0.001 or * * P = 0.001 compared with baseline within the group; †P < 0.001 compared with baseline in chronic hepatitis C.
Chronic hepatitis C (n = 31) Self-limited HCV infection (n = 12) 
Identification of T reg -cell epitopes on HCV core
Individual T reg -cell clones (1 × 10 5 ) were stimulated with single peptides P1-P12 (1 μg/ml) in the presence of autologous APCs (1 × 10 5 ). After 72 h, supernatants were harvested to measure IL-10 by ELISA.
Analysis of in vitro suppressor function of HCV core-specific T reg -cell clones
The suppressive function of individual T reg -cell clones was studied using co-culture assays with stimulated autologous Th1 and Th2 reporter clones. Reporter cells To decipher the predominant mechanism of inhibition, we compared the inhibitory capacity of anti-CD3/anti-CD28-stimulated T reg -cell clones in direct co-culture with Th1 and Th2 reporter clones (1:1 ratio) compared with transwell culture, which disrupts cell-cell contacts between T reg -cells and reporter cells (tissue culture inserts, 0.2 μm Anopore ® Membrane; Nunc). In addition, we performed blocking experiments using either a neutralizing antibody against IL-10 (clone 23738, 10 μg/ml; R&D Systems) or against the shared β-chain of IL-35 (EBI3-ATI136, 10 μg/ml; Axxora).
Statistics
All calculations were performed using Prism software package 4.0 (Graph Pad Software). Differences between experiments were compared by Fisher's exact test, Kruskal-Wallis test, Wilcoxon signed-rank test and Student's t test as appropriate. P < 0.05 was considered as statistically significant.
RESULTS
HCV reactivity of freshly isolated T reg -cell subsets in peripheral blood
In line with previous reports, we observed significantly higher baseline numbers of Foxp3 + CD25 + CD4 + Tcells in freshly isolated PBMCs from patients with chronic hepatitis C than from subjects with selflimited HCV infection. Using KARPAS-299 cells which carry the Foxp3 + CD25 high CD4 + phenotype of natural T reg -cells as a reference [21] , we found that both Foxp3 + CD25 high CD4 + and Foxp3 + CD25 int CD4 + T-cell subsets were increased in chronic hepatitis C (Table 2) .
To study the functional contribution of both CD25 + CD4 + T-cell subsets, we purified CD25 high CD4
+ and CD25 int CD4 + T-cells from PBMCs of patients with chronic hepatitis C ( Figure 1A ) and analysed their suppressive activity. As shown in Figures 1(B (Table 2) , whereas expression of the other T reg -cell markers GITR, PD-1 and CD134 remained unaffected (results not shown). In contrast with chronic hepatitis C, CD4
+ T reg -cell subsets from subjects with selflimited HCV infection remained unaltered after in vitro + CD25 int T reg -cells in advanced stages of fibrosis were detected both at baseline (r = 0.46, P = 0.02) and after HCV core stimulation (r = 0.41, P = 0.04). In contrast, none of the other T-cell subpopulations revealed any correlation to clinical parameters (results not shown).
To characterize HCV-specific T reg -cells in detail, we studied T-cell clones generated in the presence of HCV core antigen and abundant IL-2.
Identification of antigen-specific T reg -cell clones in chronic hepatitis C
Overall, we succeeded in generating 242 CD4
+ Tcell clones from seven patients with chronic hepatitis C and 65 clones from six subjects with self-limited HCV infection. On the basis of their proliferation characteristics and cytokine profiles in response to anti-CD3/anti-CD28 stimulation, we identified 23 and 14 Th1 clones, 34 and 21 Th2 clones as well as 14 and six T reg -cell clones from patients with chronic hepatitis C and subjects with self-limited HCV infection respectively (see Supplementary Tables S1 and S2 at http://www.ClinSci.org/cs/119/cs1190097add.htm).
All putative T reg -cell clones both from chronic hepatitis C (#1-#14) and self-limited HCV infection (#15-#20) were Foxp3 + and CD25 int (MFI range, 49-297) (Figure 2A ). In addition, they expressed variable levels of the other T reg -cell markers CTLA-4, GITR, PD-1, CD30, CD134 and GARP, but were consistently CD127 − (Supplementary Figure S2 at http://www.ClinSci.org/cs/119/cs1190097add.htm). Thus all clones matched the expected phenotype of T reg -cells. However, T reg -cell clones from patients with chronic hepatitis C expressed significantly higher levels of CD25 and CTLA-4 than T reg -cell clones from subjects with self-limited HCV infection ( Figure 2B ). Concerning their cytokine profiles in response to anti-CD3/anti-CD28, all T reg -cell clones produced IL-10 (Supplementary Table S2 ); and two clones from chronic hepatitis C also produced TGF-β1 (clone #5, 187.0 pg/ml; and clone #6, 963.1 pg/ml).
Of note, there was a fundamental difference in antigenspecificity between T reg -cell clones from chronic hepatitis C compared with self-limited HCV infection: 12 out of the 14 T reg -cell clones from chronic hepatitis C produced IL-10 after stimulation with HCV core antigen, whereas none of the T reg -cell clones from self-limited HCV infection recognized the core antigen ( Figure 3A) . HCV core-specificity of IL-10 responses in T reg -cell clones from chronic hepatitis C was confirmed by the absence of reactivity to a recombinant CMV antigen ( Figure 3A) . HCV core-specific IL-10 responses were restricted by HLA-DR (Supplementary Figure S3 at http://www.ClinSci.org/cs/119/cs1190097add.htm). Using overlapping peptides, we identified single epitopes which were clustered in the regions of amino acids 1-44 and 79-113 on the HCV core protein ( Figure 3B ).
Inhibitory capacity of T reg -cell clones in chronic hepatitis C
When T reg -cell clones were analysed in suppressor assays against autologous Th1 and Th2 reporter clones, all T reg -cell clones from chronic hepatitis C, but none of the clones from self-limited HCV infection, inhibited proliferation of reporter cells in a dose-dependent manner upon mitogenic stimulation (Figures 4A and 4B, and  Table 3 ). In two T reg -cell clones from chronic hepatitis C (#4 and #5), sufficient numbers of cells were available to also study the inhibitory activity against autologous reporter cells after activation with HCV core. Of note, both T reg -cell clones inhibited proliferation of reporter cells also upon antigen-specific activation ( Figure 4C ). Since adaptive T reg -cells are considered to require ongoing stimulation to maintain their regulatory activity, we next studied the in vitro stability of T reg -cell clones from chronic hepatitis C if they were further expanded with T reg -cell expander beads (Dynal) instead of HCV antigen. As shown in Figure 5 , T reg -cell clones gradually lost their suppressor function after multiple rounds of non-specific re-stimulation. This loss of function was closely correlated with reduced Foxp3 expression.
Mechanism of suppression mediated by HCV-specific T reg -cell clones
T reg -cell cells can act by contact-dependent and contactindependent mechanisms. Therefore we performed suppressor assays in a transwell system and in the presence of neutralizing antibodies. Figure 6 shows that suppression of reporter cells remained unaffected if T regcells were directly co-cultured with reporter cells or kept in transwells. Thus disrupting contact between T reg -cells and reporter T-cells did not abrogate their inhibitory capacity, suggesting that inhibition was mediated via soluble factors. In line with this concept, suppression of reporter cells by the T reg -cell clones was markedly reduced when co-culture experiments were performed in the presence of a neutralizing IL-10 antibody ( Figure 6 ). We suspected additional soluble factors other than IL-10, possibly explaining the functional difference between T reg -cell clones from chronic hepatitis C and self-limited HCV infection. As IL-35 has been described as a novel inhibitory cytokine of T reg -cells [22, 23] , we also co-cultured T reg -cells and reporter cells in the presence of a neutralizing IL-35 antibody and found that addition of anti-IL-35 also significantly blocked T reg -cell-mediated inhibitory effects ( Figure 6 ).
DISCUSSION
Accumulating evidence indicates that CD4
+ T reg -cells are expanded in humans during acute HCV infection, maintained at increased levels during the chronic stage and lowered to normal levels upon spontaneous or treatment-induced recovery [24] , suggesting that a certain balance exists between T reg -cells and effector T-cells. Our present results support this concept and provide several levels of evidence that HCV core-specific adaptive T reg -cells are present in chronic hepatitis C. First, we demonstrated that freshly isolated CD25 high and CD25 int CD4 + T-cells in chronic hepatitis C express Foxp3, as well as other markers of T reg -cells, and can inhibit CD25 − CD4 + reporter T-cells not only after stimulation with mitogen, but notably also after activation with HCV core. In line with previous reports [3] [4] [5] 16, 25, 26] + T reg -cell subsets in patients with chronic hepatitis C, but not in subjects with previous self-limited HCV infection, despite the fact that HCV-specific CD4 + Tcells usually persist long-term after elimination of the virus [27] . Finally, numbers of Foxp3 + CD25 int CD4
+ T reg -cells appeared to increase in patients with more advanced fibrosis. A rather similar relationship between Foxp3 + CD25 + CD4 + T reg -cells and hepatic fibrosis in chronic hepatitis C has also been reported by Marché and co-workers in the liver [28] ; however, their study did not address antigen specificity.
To further study HCV core-specific T reg -cells, we established T-cell clones in the presence of HCV core including abundant IL-2 and succeeded in generating 14 and six T reg -cell clones from patients with chronic hepatitis C and subjects with self-limited HCV infection respectively. At a first glance, T reg -cell clones from either group exhibited rather similar features: all clones were hypoproliferative, expressed Foxp3, as well as other T regcell markers, and produced substantial amounts of IL-10. However, T reg -cells clones were CD25 int and expressed rather moderate levels of Foxp3, which distinguished them from natural T reg -cells [9, 10] .
Nevertheless, we found marked differences between T reg -cell clones from chronic hepatitis C and selflimited HCV infection: T reg -cell clones from self-limited HCV had lower CD25 and CTLA-4 expression levels, were not active in autologous suppressor assays and did not respond to HCV core. In contrast, T reg -cell clones from chronic hepatitis C inhibited proliferation of autologous Th1 and Th2 reporter clones, and were
Figure 3 Identification of HCV core-specific T reg -cell clones in chronic hepatitis C
(A) HCV core-specific secretion of IL-10 was selectively found in T reg -cell clones from patients with chronic hepatitis C, but not in T reg -cell clones from subjects with self-limited HCV infection. Antigen-specificity was confirmed by the absence of reactivity upon stimulation with CMV control antigen. Both T reg -cell clones from chronic hepatitis C and from self-limited HCV infection secreted IL-10 upon stimulation with anti-CD3/anti-CD28. Statistical comparisons were performed using an unpaired Student's t test. Ø, unstimulated cells. (B) HCV core-specific T reg -cell clones from chronic hepatitis C responded to distinct peptides of the HCV core protein. T reg -cells were stimulated with single peptides (P1-P12, 1 μg/ml) from our HCV core 25-mer peptide panel in the presence of autologous APCs. After 72 h, IL-10 secretion was measured in the supernatants by ELISA. A representative stimulation experiments is shown in which two T reg -cell clones (clone #2 upper left-hand panel and clone #6 upper right-hand panel) selectively respond to peptide P2 (amino acids 10-34) and P10 (amino acids 89-113) respectively. The Table summarizes the peptide epitope specificities, demonstrating that recognized peptides were clustered in regions containing amino acids (aa) 1-44 and 79-113 on the HCV core protein.
specifically activated by recombinant HCV core in an HLA-DR-restricted fashion. Although our present experiments were somewhat limited by the low number of cells available, we also found that activation with HCV core led to inhibition of reporter T-cells by the two T reg -cell clones, which we could study in antigen-specific suppressor assays. Taken together, these findings indicated that we had cloned HCV core-specific adaptive T reg -cells from chronic hepatitis C, whereas Tcells with a rather similar phenotype from self-limited HCV infection exhibited neither HCV-specificity nor functional activity.
Epitope mapping with 25-mer peptides confirmed that T reg -cells from chronic hepatitis C were activated by single epitopes which clustered to two regions on HCV core (amino acids 1-44 and 79-113). It is noteworthy that the same regions have been shown previously to harbour major epitopes of HCV Figure 4 Functional characterization of T reg -cell clones from subjects with different outcomes of HCV infection (A) T reg -cell clones raised from chronic hepatitis C inhibited proliferation of autologous reporter clones in a dose-dependent manner. The representative example illustrates that co-culture of anti-CD3/anti-CD28-stimulated T reg -cells (T reg -cell clone #1) in increasing ratios (1:4, 1:2 and 1:1) and a Th1 reporter clone (clone T5_4; 5 × 10 4 cells/well) significantly reduced proliferation of the reporter cells. The inhibition of the reporter clone T5_4 by T reg -cell clone #1 was confirmed in four independent experiments. Statistical comparison was performed using the Kruskal-Wallis test. A summary of all of the co-culture suppression assays is given in Table 3 . (B) Hypoproliferative IL-10-producing CD4
+ T reg -cell clones from subjects with self-limited HCV infection failed to inhibit proliferation of reporter clones. A representative co-culture experiment is shown using anti-CD3/anti-CD28-stimulated (1 μg/ml and 2.5μg/ml) autologous Th2 reporter clone DK5_6 (5 × 10 4 cells/well) with T reg -cell clones #15, #16 and #17 (at a 1:1 ratio) generated from subjects with self-limited HCV infection. Proliferative responses were analysed via [
3 H]thymidine incorporation (in c.p.m.) after 5 days. Statistical comparison was performed using the Kruskal-Wallis test. n.s., not significant. Values are means + − S.E.M. (C) T reg -cell clones from chronic hepatitis C suppressed the proliferation of autologous reporter clones upon stimulation with HCV core antigen. The immunosuppressive capacity of the two available HCV-specific T reg -cell clones generated from patients with chronic hepatitis C (clone #4 and #5) against their autologous reporter clones after stimulation with HCV core protein is shown. After 5 days, proliferative responses were analysed via [
3 H]thymidine incorporation. Treg, T reg -cell; Trep, reporter T-cell.
core-specific effector T-cells [17, 18] . Thus shared HCV core epitopes recognized by both conventional effector T-cells and T reg -cells may be a hint that adaptive T reg -cells in chronic hepatitis C are activated in parallel to maintain a certain balance in the regulation of the immune response [29] .
HCV core protein is abundant during chronic infection but absent after viral elimination. Importantly, HCV core-specific adaptive T reg -cells appear to be closely linked to continued antigen exposure. This idea is supported by our present in vitro studies, which indicated that T reg -cell clones gradually lost their Foxp3 expression and inhibitory activity if cultured without HCV core protein. Thus, in analogy to our experiments in T regcell clones, freshly isolated Foxp3 + CD25 + CD4 + T-cells from subjects with previous self-limited HCV infection might have not responded to HCV core stimulation, because HCV core-specific T reg -cells had disappeared after antigen elimination. This mechanism can also explain why we were unable to establish HCV corespecific T reg -cell clones from subjects with self-limited HCV infection.
Our HCV core-specific T reg -cell clones differ from T reg -cells in HCV infection described by other groups with respect to several features [3] [4] [5] [6] [7] [8] . For instance, they differ from the HCV-specific T reg -cells described by Ebinuma et al. [30] , which had been studied after stimulation with non-structural proteins NS3 and NS4, because their T reg -cells were CD25 high and did not produce IL-10 or TGF-β1. Thus it remains an interesting, but unproven idea, that several types of distinct adaptive CD4
+ T reg -cell subsets exist, the phenotypic and functional differentiation of which may reflect activation by distinct HCV antigens (core in our present study compared with NS3/NS4 in the study by Ebunima et al. [30] ).
A further difference concerns the mechanisms underlying the inhibitory activity in our T reg -cell clones, because most T reg -cells in hepatitis C appear to involve contact-dependent mechanisms of inhibition [3, 4, 6, 8] . Despite some heterogeneity in the individual expression of T reg -cell markers, which is a characteristic feature of adaptive T reg -cells [11] [12] [13] , all T reg -cell clones from chronic hepatitis C expressed CTLA-4 or PD-1, which are pivotally involved in contact-mediated Tcell inhibition. Moreover, CTLA-4 expression was substantially higher on T reg -cell clones from chronic hepatitis C than from self-limited HCV infection. Nevertheless, our transwell co-culture experiments clearly indicated that T reg -cell clones from chronic hepatitis C suppressed reporter T-cells via the inhibitory cytokines IL-10 and IL-35. These findings are in line with recent observations in mice suggesting that activation of T reg -cells might require some cell contact, whereas in activated cells immunosuppressive functions were mediated via release of IL-10 and IL-35 [31] . Foxp3 In the absence of antigen-specific activation, HCV core-specific T reg -cell clones from chronic hepatitis C gradually lost Foxp3 expression, which closely correlated with reduced immunosuppressive function in co-culture assays. In brief, following multiple rounds of non-specific antigen stimulation (each 10 days apart), levels of detectable Foxp3 within T reg -cells decreased. Histograms of Foxp3 staining (thick lines) and isotype controls (thin lines) are shown on the right-hand side. In correlation, T reg -cell clones also lost their abilitity to suppress autologous reporter T-cells. The left-hand panel shows a reduction in [
3 H]thymidine uptake as a percentage of specific inhibition after 5 days of co-culture. Treg, T reg -cell; Trep, reporter T-cell. expression appears to be an important factor in this process, since Foxp3 can enhance IL-10 secretion, because in vitro experiments transfecting Foxp3 into CD25 − CD4 + T-cells resulted in increased IL-10 mRNA levels [32, 33] . This relationship between Foxp3 and cytokine enhancement possibly explains our observation that T reg -cell clones lost their immunosuppressive capacity when Foxp3 expression disappeared. Several studies have already provided some indications that T reg -cells may be antigen-specific during HCV infection [4, 5, 34] . Li et al. [5] reported that, unlike controls, in vitro culture of PBMCs from HCVinfected patients with HCV-derived peptides resulted in rapid induction of Foxp3
T reg -cells has been observed during acute hepatitis C [34] [35] [36] . Nevertheless, the functional role of T reg -cells has remained unclear. Although Perella et al. [35] identified T reg -cell expansion as a risk factor for chronic infection, other groups reported that increases in T reg -cell numbers were independent of the clinical outcome of disease [34, 36] . Finally, the finding of a relationship between numbers of T reg -cells and fibrosis in the study by Marché et al. [28] and our present study suggests that T reg -cells may be linked in some way to tissue damage in hepatitis C. To this discussion our present results also add the novel finding that functionally active T reg -cells with specificity for HCV core exist in chronic hepatitis C. These cells require continued antigen exposure to maintain their Foxp3 expression and inhibitory capacity. Since we could not detect such adaptive T reg -cells in subjects after spontaneous resolution of their HCV infection, this type of T reg -cell is either not generated during acute HCV infection or is lost after spontaneous resolution in the subjects with self-limited HCV infection. Thus evolution of T reg -cells should be studied further during the various phases of infection as well as in the liver in order to better understand their contribution to the altered balance of immunoregulation and tissue damage in hepatitis C. Induction of IL-10 after HCV core stimulation is HLA class II-restricted. Three HCV-specific T reg -cell (Treg) clones from patients with chronic hepatitis C were stimulated with HCV core protein in the presence of monoclonal antibodies against HLA-DR (10 μg/ml), HLA-DQ (10 μg/ml) and HLA-DP (10 μg/ml). After 72 h, supernatants were collected and tested for IL-10 secretion by ELISA. . A total of 162 and 47 clones from chronic hepatitis C and self-limited HCV infection respectively, were considered indeterminate, because their cytokine and proliferation profiles did not enable allocation to Th1 cell, Th2 cell or T reg -cell clones; 62 % of these clones also produced IL-10. 
FUNDING
